TREATMENT OF PANCREATIC PSEUDOCYST THROUGH ROUX-EN-Y CYSTOJEJUNOSTOMY
Abstract:
The pancreas pseudocyst is one of the most important late complications (3-6 weeks) of severe acute pancreatitis with an incidence of 10-15% and has a proportional increase in the severity of pancreatitis. Major advances in the diagnostic and therapeutic strategy of acute pancreatitis over the past few years have influenced the therapeutic attitude in the pancreas pseudocyst, so that old protocols such as “any 6 cm diameter pseudocyst must be operated immediately” or “each day of surgery delay increases possibility of complications” are no longer accepted and used. Today, pancreatic pseudocyst treatment benefits from two distinct therapeutic pathways: conservative therapy, associated with dynamic monitoring and follow-up to complete resorption, and pseudocyst drainage (endoscopically, percutane guided echographically and surgically).(1,2,3)
full text article in English (.EN) |